For the quarter ending 2025-09-30, IVVD had $50,062K increase in cash & cash equivalents over the period. -$8,250K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -10,470 | -30,949 |
| Stock-based compensation expense | 3,073 | 6,006 |
| Amortization of operating lease right-of-use assets | 282 | 784 |
| Depreciation and amortization expense | 149 | 457 |
| Other non-cash adjustments | -205 | -91 |
| Accounts receivable | 1,360 | -2,091 |
| Inventory | -50 | 71 |
| Prepaid expenses and other current assets | -562 | -4,797 |
| Other non-current assets | -10 | -18 |
| Deferred revenue | - | 0 |
| Accounts payable | -218 | 7,675 |
| Accrued expenses | -251 | -24,580 |
| Operating lease liabilities | -289 | -747 |
| Other current liabilities | 7 | -2 |
| Other non-current liabilities | 0 | 0 |
| Net cash used in operating activities | -8,250 | -34,430 |
| Purchases of property and equipment | 0 | 155 |
| Net cash used in investing activities | 0 | -155 |
| Proceeds from exercises of stock options | 0 | 105 |
| Proceeds from issuance of common stock under the employee stock purchase plan | 56 | 122 |
| Proceeds from at-the-market offering, net of commissions | 4,484 | - |
| Proceeds from underwritten public offering, net of underwriting discounts and commissions | 54,048 | - |
| Proceeds from issuance of common stock, net of issuance costs | - | 0 |
| Payments for at-the-market offering costs | 145 | - |
| Payments for offering costs | - | 86 |
| Payments for underwritten public offering costs | 217 | - |
| Net cash provided by financing activities | 58,312 | 141 |
| Net increase (decrease) in cash and cash equivalents | 50,062 | -34,444 |
| Cash and cash equivalents at beginning of period | 69,349 | - |
| Cash and cash equivalents at end of period | 84,967 | - |
Invivyd, Inc. (IVVD)
Invivyd, Inc. (IVVD)